Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003873 · ClinicalTrials.gov registry record · Phase 3
Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
A Phase 3 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 950
- Enrollment target
NCT00003873: Completed Phase 3 study, sponsored by National Cancer Institute (NCI).
NCT00003873 is a Phase 3 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 950 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003873, a Phase 3 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 950 participants
- Enrollment target
Study Summary
Randomized phase III trial to compare the effectiveness of fluorouracil given by infusion with that of fluorouracil plus eniluracil given by mouth in treating patients who have metastatic, recurrent, or residual advanced colorectal cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if fluorouracil is more effective with or without eniluracil for advanced colorectal cancer
Interventions
- DRUG fluorouracil
- DRUG eniluracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 950 participants |
| Start Date | 1999-04 |
| Phase | Phase 3 |
What the finished NCT00003873 record still lists
NCT00003873 is an interventional study that assigns participants to a tested intervention. The registered 950 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 2 interventions - of which fluorouracil is the first listed.
NCT00003873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003873 about?
NCT00003873 is a clinical study titled "Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer". Randomized phase III trial to compare the effectiveness of fluorouracil given by infusion with that of fluorouracil plus eniluracil given by mouth in treating patients who have metastatic, recurrent, or residual advanced colorectal cancer. Drugs used in chemotherapy use different ways to stop tumor ...
What is the current status of trial NCT00003873?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 950 participants. The study started on 1999-04.
What interventions are being tested in trial NCT00003873?
The interventions under investigation include: fluorouracil (DRUG), eniluracil (DRUG).
Who is sponsoring clinical trial NCT00003873?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00003873's enrollment target sits among peer trials
950 333rd of 2000 higher than 1,667 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT04375033 · 952 participants · Phase 4
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia